79606-51-2Relevant articles and documents
NUCLEAR RECEPTOR BINDING AGENTS
-
Page/Page column 107; 135-137; 140, (2008/06/13)
The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.